Upload Avatar (500 x 500)
Min Guan
min.guan@siat.ac.cn
Chinese, English
Guangdong
University of Chinese Academy of Sciences
Life Sciences
  • 2006-09 to 2009-07 PhD: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
  • 2001-09 to 2004-07 Master's: Jinan University
  • 1997-09 to 2001-07 Bachelor's: South China Normal University
  • 2018-01 to Present - Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences - Researcher (PI)
  • 2013-01 to 2017-12 - Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences - Associate Researcher (PI)
  • 2011-12 to 2012-12 - Johns Hopkins University School of Medicine - Postdoctoral Researcher
  • 2009-11 to 2011-11 - University of California, Davis School of Medicine - Postdoctoral Researcher
  • Guangdong Province High-Level Talent Special Support Program for Young Top Talents in Technological Innovation (2018): Special Prize
  • Member of the Youth Promotion Association of the Chinese Academy of Sciences (2015)
  • Funding for Science and Technology Activities of Returned Overseas Students (2015): Ministry Level
  • Shenzhen Overseas High-Level Peacock Program Category B Talent (2014): Second Prize
  • Outstanding Postdoctoral Award, University of California, Davis School of Medicine (2011): Special Prize
  • ASBMR-Lilly/Pfizer Young Investigator Award, American Society for Bone and Mineral Research (2011): Special Prize
  • Alice L. Jee Memorial Young Investigator Award, International Bone Mineral Society (2011): Special Prize
Bone and Joint Diseases
Metabolic Diseases
Drug Development
Metabolic Regulation
Stem Cells and Tissue Regeneration
Nuclear Receptors and Transcriptional Regulation
  • Targeting adipocyte ESRRA promotes osteogenesis and vascular formation in adipocyte-rich bone marrow, Corresponding Author, 2024
  • Sesquiterpenoids from Alpinia oxyphylla with GLP-1 Stimulative Effects through Ca 2+ /CaMKII and PKA Pathways and Multiple-Enzyme Inhibition, 5th Author, 2023
  • Nicotine rebalances NAD(+) homeostasis and improves aging-related symptoms in male mice by enhancing NAMPT activity, 7th Author, 2023
  • Andrographolide Inhibits Intestinal Lipid Secretion via Antagonizing Estrogen-Related ReceptorαActivity, Corresponding Author, 2023
  • Oligostilbenes from the seeds of Paeonia lactiflora as potent GLP-1 secretagogues targeting TGR5 receptor, 5th Author, 2022
  • A programmed surface on polyetheretherketone for sequentially dictating osteoimmunomodulation and bone regeneration to achieve ameliorative osseointegration under osteoporotic conditions, 7th Author, 2022
  • Highly Purified Eicosapentaenoic Acid Alleviates the Inflammatory Response and Oxidative Stress in Macrophages during Atherosclerosis via the miR-1a-3p/sFRP1/Wnt/PCP-JNK Pathway, 8th Author, 2022
  • Programmed surface on poly(aryl-ether-ether-ketone) initiating immune mediation and fulfilling bone regeneration sequentially, 9th Author, 2021
  • Strontium regulates stem cell fate during osteogenic differentiation through asymmetric cell division, 5th Author, 2021
  • ZnL 2-BPs Integrated Bone Scaffold under Sequential Photothermal Mediation: A Win-Win Strategy Delivering Antibacterial Therapy and Fostering Osteogenesis Thereafter, 6th Author, 2021
  • An ERRα antagonist Compound 29 protects against obesity-induced osteoclastic bone loss, Corresponding Author, 2021
  • Communication:The Role of Metabolic Regulation and Differentiation in Bone Cells, Corresponding Author, 2021
  • Andrographolide prevents bone loss via targeting estrogen-related receptor-alpha-regulated metabolic adaption of osteoclastogenesis, Corresponding Author, 2021
  • Lipid Disorders in NAFLD and Chronic Kidney Disease, Corresponding Author, 2021
  • Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease, Corresponding Author, 2021
  • Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development, Corresponding Author, 2020
  • Aptasensor-enabled quantitative analysis of nanosized extracellular vesicles by flow cytometry, 7th Author, 2020
  • Circulating MicroRNA-19b Identified From Osteoporotic Vertebral Compression Fracture Patients Increases Bone Formation, Corresponding Author, 2020
  • Andrographolide modulates HNF4 alpha activity imparting on hepatic metabolism, Corresponding Author, 2020
  • 18 beta-Glycyrrhetinic acid acts through hepatocyte nuclear factor 4 alpha to modulate lipid and carbohydrate metabolism, Corresponding Author, 2020
  • Zinc Homeostasis in Bone: Zinc Transporters and Bone Diseases, Corresponding Author, 2020
  • Tuning the surface immunomodulatory functions of polyetheretherketone for enhanced osseointegration, 8th Author, 2020
  • Near-infrared light control of bone regeneration with biodegradable photothermal osteoimplant, 9th Author, 2019
  • Estrogen-related receptor gamma regulates hepatic triglyceride metabolism through phospholipase A2 G12B, 5th Author, 2019
  • Runx2/Osterix and Zinc Uptake Synergize to Orchestrate Osteogenic Differentiation and Citrate Containing Bone Apatite Formation., Corresponding Author, 2018
  • Scavenger receptor-mediated Ad5 entry and acLDL accumulation in monocytes/macrophages synergistically trigger innate responses against viral infection, 6th Author, 2018
  • Aging Reduces an ERRalpha-Directed Mitochondrial Glutaminase Expression Suppressing Glutamine Anaplerosis and Osteogenic Differentiation of Mesenchymal Stem Cells., Corresponding Author, 2017
  • Lactose-Functionalized Gold Nanorods for Sensitive and Rapid Serological Diagnosis of Cancer, 6th Author, 2016
  • Activation of farnesoid X receptor promotes triglycerides lowering by suppressing phospholipase A2 G12B expression, Corresponding Author, 2016
  • Bone turnover and articular cartilage differences localized to subchondral cysts in knees with advanced osteoarthritis, Not mentioned, 2015
  • Elevated Mean Arterial Pressure Is Associated With Higher Rate of Subchondral Bone Turnover in Patients With Knee Osteoarthritis., 2nd Author, 2014
  • Reversing Bone Loss by Directing Mesenchymal Stem Cells to Bone, 2nd Author, 2013
  • Wntless functions in mature osteoblasts to regulate bone mass, 8th Author, 2012
  • Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass, 1st Author, 2012
  • Glucocorticoid dose determines osteocyte cell fate, 3rd Author, 2011
  • Hepatocyte nuclear factor-4 alpha regulates liver triglyceride metabolism in part through secreted phospholipase A2 GXIIB, 1st Author, 2011
  • Inhibition of the Progesterone Nuclear Receptor during the Bone Linear Growth Phase Increases Peak Bone Mass in Female Mice, 7th Author, 2010
Bone Joint Metabolism Disease Drug Development Regulation Stem Cells Regeneration Nuclear Receptors

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.